Leukocyte cytokine expression is associated with severity of autism in children
- Authors: Filippova Y.Y.1, Alekseeva A.S.1, Burmistrova A.L.1
-
Affiliations:
- Chelyabinsk State University
- Issue: Vol 26, No 4 (2023)
- Pages: 593-598
- Section: Forum Sochi 2023
- URL: https://journal-vniispk.ru/1028-7221/article/view/253448
- DOI: https://doi.org/10.46235/1028-7221-13911-LCE
- ID: 253448
Cite item
Full Text
Abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with unknown etiology, high clinical heterogeneity and marked aberrations of the immune system. Evidence for an association between immune dysfunction and behavioral traits highlights the need for a study of the immune cell functional activity in order to search for pathogenesis mechanisms and potential targets for therapy at ASD. The purpose: to determine the expression levels of IL-1β, IL-2, IL-4, IL-6, IL-10, IL-18, IFNγ and TNFα in peripheral blood leukocytes of children with mild and severe ASD. The study included 81 children with ASD (77.8% boys) and 45 children with typical neurodevelopment (TDC, 71.1% boys). According to the Childhood Autism Rating Scale, 51 children (63.0%) had mild autistic symptoms (CARS score 32.0±1,5) and 30 children had severe ASD symptoms (CARS score 39.0±3,4). Cytokines expression in leukocytes was determined by quantitative PCR with SYBRGreen. The data were transformed using Box–Cox transformation. The differences between groups were assessed by one-way ANOVA and Dunn’s test for multiple comparisons. In leukocytes of children with ASD, regardless of the severity, the expression of IL-1β, IL-18 and IL-2, was significantly reduced compared to TDC. Moreover, in children with mild ASD, low expression of TNFα, compared with TDC was found. In children with severe ASD, the expression of the main cytokine of Th1 – IFNγ, was significantly increased, without an increased expression of an important cytokine of Treg – IL-10. Activation of the Th1 adaptive immune response without compensation by cytokines of Treg, the number of which is reduced in ASD, can lead to increased inflammation, even in the central nervous system, and correlates with the severity of ASD clinical symptoms. Despite extensive immunological evidence suggesting immune system dysregulation, further research is required to clarify the relationship between immune system cell function and ASD pathology.
Full Text
##article.viewOnOriginalSite##About the authors
Yuliya Y. Filippova
Chelyabinsk State University
Author for correspondence.
Email: julse@rambler.ru
ORCID iD: 0000-0001-5041-6440
PhD (Biology), Associate Professor, Department of Microbiology, Immunology and General biology, Faculty of Biology, Chelyabinsk State University
Russian Federation, ChelyabinskA. S. Alekseeva
Chelyabinsk State University
Email: 96_anya@mail.ru
ORCID iD: 0000-0002-2524-8569
Postgraduate Student, Department of Microbiology, Immunology and General Biology, Faculty of Biology, Chelyabinsk State University
Russian Federation, ChelyabinskA. L. Burmistrova
Chelyabinsk State University
Email: burmal@csu.ru
ORCID iD: 0000-0001-6462-9500
PhD, MD (Medicine), Professor, Head, Department of Microbiology, Immunology and General Biology, Faculty of Biology, Chelyabinsk State University
Russian Federation, ChelyabinskReferences
- Бурмистрова А.Л., Алексеева А.С., Казо М.Е., Филиппова Ю.Ю. Лейкоцитарная сигнатура микроРНК в контексте хронического системного воспаления при сосудистой деменции // Российский иммунологический журнал, 2022. Т. 25, № 4. С. 399-404. [Burmistrova A.L., Alekseeva A.S., Cazaux M.E., Filippova Yu. Yu. MicroRNA signature of leukocytes in the context of chronic systemic inflammation in vascular dementia. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2022, Vol. 25, no. 4, pp. 399-404. (In Russ.)] doi: 10.46235/1028-7221-1187-MSO.
- Филиппова Ю.Ю., Девятова Е.В., Алексеева А.С., Бурмистрова А.Л. Цитокины и нейротрофические факторы в оценке степени тяжести аутизма у детей // Клиническая лабораторная диагностика, 2022. Т. 67, № 11. С. 647-651. [Filippova Yu.Yu., Devyatova E.V., Alekseeva A.S., Burmistrova A.L. Cytokines and neurotrophic factors in assessing the severity of autism in children. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2022, Vol. 67, no. 11, pp. 647-651. (In Russ.)]
- Dipasquale V., Cutrupi M.C., Colavita L., Manti S., Cuppari C., Salpietro C. Neuroinflammation in autism spectrum disorders: role of high mobility group box 1 protein. Int. J. Mol. Cell. Med., 2017, Vol. 6, no. 3, pp. 148-155.
- Kutuk M.O., Tufan E., Gokcen C., Kilicaslan F., Karadag M., Mutluer T., Yektas C., Coban N., Kandemir H., Buber A., Coskun S., Acikbas U., Guler G., Topal Z., Celik F., Altintas E., Giray A., Aka Y., Kutuk O. Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey. Cytokine, 2020, Vol. 133, 155152. doi: 10.1016/j.cyto.2020.155152.
- Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol., 2009, Vol. 207, pp. 111-116.
- Masi A., Glozier N., Dale R., Guastella A.J. The immune system, cytokines, and biomarkers in autism spectrum disorder. Neurosci. Bull., 2017, Vol. 33, no. 2, pp. 194-204.
- Meltzer A., van de Water J. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology, 2017, Vol. 42, no. 1, pp. 284-298.
- Nie Z.Q., Han D., Zhang K., Li M., Kwon H.K., Im S.H., Xu L., Yang J., Li Z.W., Huang X.W., Wen J., Shu-Jun Y., Yin F., Shen C., Ashwood P., Kang C.Y., Cao X. TH1/Treg ratio may be a marker of autism in children with immune dysfunction. Research in Autism Spectrum Disorders, 2023, Vol. 101, 102085. doi: 10.1016/j.rasd.2022.102085.
- Plotnikova M.A., Klotchenko S.A., Vasin A.V. Development of a multiplex quantitative PCR assay for the analysis of human cytokine gene expression in influenza A virus-infected cells. J. Immunol. Methods, 2016, Vol. 430, pp. 51-55.
- Singh R., Kisku A., Kungumaraj H., Nagaraj V., Pal A., Kumar S., Sulakhiya K. Autism spectrum disorders: a recent update on targeting inflammatory pathways with natural anti-inflammatory agents. Biomedicines, 2023, Vol. 11, no. 1, 115. doi: 10.3390/biomedicines11010115.
Supplementary files
